The global apoptosis receptor BAX market is anticipated to grow at a significant CAGR of 6.2% during the forecast period 2022-2028. The rising biomedical research activities is a major factor attributing to the growth of the market. For instance, according to the research paper published on BMJ Publishing Group Ltd & British Society of Gastroenterology in February 2022, the Bax/Bcl-2 system did not seem to be involved in induction of apoptosis of epithelial cells in the inflamed colonic mucosa of UC. Similarly, the scientists of Albert Einstein College of Medicine in March 2022 had found that the combination of BTSA1.2 and Navitoclax is effective against the treatment of various types of cancer as BTSA1.2 boosting active BAX to toxic levels in cancer cells, and Navitoclax acting as BAX’s bodyguard by preventing BCL-XL from neutralizing BAX. Such researches are further expected to generate growth opportunities for the market in the future.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/apoptosis-regulator-bax-market
The market players are also contributing significantly in the growth of the global apoptosis receptor BAX market by adopting various business strategies, such as mergers and acquisitions, regional expansion, partnerships and collaborations, and new product releases to remain competitive in the market. For instance, in August 2020, Verrica Pharmaceuticals entered into an exclusive global licensing agreement with Lytix Biopharma to develop and commercialize LTX-315 for dermatologic oncology indications. Verrica intends to focus initially on basal cell and squamous cell carcinomas as the lead indications for development. LTX-315 (Ruxotemitide) is a potential candidate in the soft tissue sarcoma pipeline owing to its ability to fully personalize immunotherapy by its mode of action to use the patient’s own tumor as its own vaccine, expose the immune system to one patient’s own cancer antigens, and generate patient-specific antitumor immunity. LTX-315 is the oncolytic peptide that kills cancer cells through Bax/Bak-regulated mitochondrial membrane permeabilization.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape – including, Genervon Biopharmaceuticals LLC, Lytix Biopharma AS, Huons Co. Ltd., among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Apoptosis Receptor BAX Market Report Segment
By Type
- GM-6
- HU-010
- LTX-401
- Others
By Application
- Liver Cancer
- Stroke
- Melanoma
- Parkinson’s Disease
- Others
A full report of Apoptosis Regulator BAX Market is available at: https://www.omrglobal.com/industry-reports/apoptosis-regulator-bax-market
Apoptosis Regulator BAX Market– Segment by Region
North America
- United States
- Canada
Europe
- Germany
- United Kingdom
- France
- Spain
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Rest of Asia-Pacific
Rest of the World
- Middle East & Africa
- Latin America
Company Profiles
- Genervon Biopharmaceuticals LLC
- Huons Co. Ltd.
- Plexxicon Inc.
- Proximagen Ltd.
- Rottapharm Biotech Srl
- Sienna Biopharmaceuticals Inc.
- Tiziana Life Sciences PLC
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
